First Hawaiian Bank »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by First Hawaiian Bank

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by First Hawaiian Bank from 13F filings

Historical chart of First Hawaiian Bank investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by First Hawaiian Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by First Hawaiian Bank

Quarter filed Position value Share count Share price at filing
2024-09-30 $147k 124k 1.19
2024-06-30 $62k 56k 1.11
2024-03-31 $87k 90k 0.97
2023-12-31 $183k 198k 0.93

More positions owned by First Hawaiian Bank

Ishares Core S&p500 Etf (IVV)
State Street ETF/USA Tr Unit (SPY)
Ishares Core Msci Eafe (IEFA)
Vanguard Etf/usa Vng Rus1000grw (VONG)
Vanguard ETF/USA Value Etf (VTV)
iShares ETFs/USA Core Msci Emkt (IEMG)
iShares ETFs/USA Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
Vanguard ETF/USA Intl High Etf (VYMI)
Ishares S&p 500 Grwt Etf (IVW)
BlackRock Fund Advisors Core Us Aggbd Et (AGG)
State Street Etf/usa Utser1 S&pdcrp (MDY)
Ishares S&p 500 Val Etf (IVE)
Apple (AAPL)
Vanguard S&p 500 Etf Shs (VOO)

View all positions for First Hawaiian Bank

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1